Eton Pharmaceuticals Provides Update on ET-105 Program

DEER PARK, Ill., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today provided an update on its...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news